ATYR Pharma(ATYR.US)

Last Updated 19:00:00 ET
longbridge loading

RBC Capital Sticks to Its Hold Rating for aTyr Pharma (ATYR)

Tip Ranks·
US
ATYR
-7.03%
US
SBIO
-1.24%
US
IBB
+0.10%
Tip Ranks·
US
ATYR
-7.03%
US
SBIO
-1.24%
US
IBB
+0.10%

ATYR Pharma | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
ATYR
-7.03%
Earnings Watch·
US
ATYR
-7.03%

ATYR Pharma | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
ATYR
-7.03%
Earnings Watch·
US
ATYR
-7.03%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
QUCY
-23.64%
US
STAA
+0.90%
US
ALP
-0.36%
benzinga_article·
US
QUCY
-23.64%
US
STAA
+0.90%
US
ALP
-0.36%

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga_article·
US
SMTI
+3.79%
US
ATYR
-7.03%
US
ERNA
-6.53%
benzinga_article·
US
SMTI
+3.79%
US
ATYR
-7.03%
US
ERNA
-6.53%

aTyr Pharma (ATYR) Receives a Hold from Wells Fargo

Tip Ranks·
US
ATYR
-7.03%
Tip Ranks·
US
ATYR
-7.03%

aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial

Market Beat·
US
ATYR
-7.03%
US
BBH
+0.68%
US
IBB
+0.10%
Market Beat·
US
ATYR
-7.03%
US
BBH
+0.68%
US
IBB
+0.10%

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga_article·
US
PACS
-0.24%
US
WOK
-38.16%
US
ABCL
-2.64%
benzinga_article·
US
PACS
-0.24%
US
WOK
-38.16%
US
ABCL
-2.64%
© 2026 Longbridge｜Disclaimer